Rodman & Renshaw is pleased to announce that the Acumen BioFin
Rodman & Renshaw 4th Annual Global Healthcare Conference will take
place at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco, on
May 14-15, 2007.
Join us and you will witness presentations by more than
200 emerging growth biotechnology companies at an event that rapidly
has become the premier event on the Life Sciences calendar. Companies
will share their accomplishments on an array of therapeutic topics
including oncology, cardiovascular disease, central nervous system
disorders, infectious diseases and medical device technology. The
event will unite companies with institutional investors, venture
capitalists, senior corporate executives and experts from the
scientific and medical communities.
The Conference will include company presentations, breakout
sessions, and one-on-one meetings with presenting companies.
On May 14th, Rodman & Renshaw will host a Conference-wide Gala
Dinner at the Salle Des Etoiles. This will be an Evening of Laughter,
Performance and Intrigue.
The Gala Dinner is for Conference attendees only and seating is
very limited.
Institutional Investors, Venture Capitalists, Sophisticated
Private Investors, Business Development & Partnering Executives and
Scientific Experts from the worldwide medical and research communities
are welcome to join us for one of the premier events on the Life
Sciences Calendar.
For Registration and Further Information, please contact Lily
Khaykina at 212-430-1714 or email: LK@rodmanandrenshaw.com
You may also REGISTER ONLINE
at: www.rodmanandrenshaw.com/eu07conference
To view the list of confirmed presenting companies, please visit:
www.rodmanandrenshaw.com/eu07conference
Note to Editors:
Rodman & Renshaw, LLC is a privately-held, full-service investment
bank committed to fostering the long-term success of emerging growth
companies through capital raising, strategic advice, insightful
research and the development of institutional support. During the
last three years, Rodman & Renshaw completed over 100 financing
transactions, totaling over $1.75 billion. Rodman & Renshaw
concentrates on emerging growth companies in the life science and
technology sectors.
